.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Farmers Insurance
Queensland Health
Teva
US Department of Justice
Citi
Cantor Fitzgerald
Johnson and Johnson
Covington
Express Scripts

Generated: June 22, 2017

DrugPatentWatch Database Preview

DISOPHROL Drug Profile

« Back to Dashboard

Which patents cover Disophrol, and what generic Disophrol alternatives are available?

Disophrol is a drug marketed by Schering Plough and Schering and is included in two NDAs.

The generic ingredient in DISOPHROL is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.

Summary for Tradename: DISOPHROL

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list13
Patent Applications: see list665
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DISOPHROL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering Plough
DISOPHROL
dexbrompheniramine maleate; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL013483-004Sep 13, 1982DISCNNoNo► Subscribe► Subscribe
Schering
DISOPHROL
dexbrompheniramine maleate; pseudoephedrine sulfate
TABLET;ORAL012394-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Merck
Mallinckrodt
Harvard Business School
Accenture
US Department of Justice
QuintilesIMS
Cantor Fitzgerald
Boehringer Ingelheim
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot